Review on Antidiabetic Effects of Euphorbia hirta L. via Digestive Enzyme Inhibition

Authors

  • Vikas Kumar Suyash Institute of Pharmacy, Hakkabad, Gorakhpur, U.P., India-273016
  • Dr. Pankaj Tripathi Suyash Institute of Pharmacy, Hakkabad, Gorakhpur, U.P., India-273016
  • Mr. Shekhar Singh Suyash Institute of Pharmacy, Hakkabad, Gorakhpur, U.P., India-273016
  • Saurabh Shukla School of Pharmacy and Research Centre, Sanskriti University, Chhata, Mathura, Uttar Pradesh, India

DOI:

https://doi.org/10.62752/ijphi.v3i2.257

Keywords:

Euphorbia hirta L. Antidiabetic effects, Digestive enzyme inhibition, α-glucosidase, α-amylase

Abstract

A lot of people are curious about the antidiabetic properties of the medicinal plant Euphorbia hirta L., which has a long history of usage in traditional medicine. Focusing on its ability to block digestive enzymes that assist in glucose metabolism, this article critically examines the mechanisms of action underlying Euphorbia hirta's antidiabetic efficacy. Euphorbia hirta's bioactive substances reduce glucose absorption and improve glycemic management by inhibiting α-amylase and α-glucosidase enzymes. Multiple studies, both in the laboratory and in living organisms, have demonstrated that this plant can help diabetic patients lower their blood glucose levels, increase their insulin sensitivity, and reduce their levels of oxidative stress. Phytochemical studies have shown the presence of phenolic chemicals, alkaloids, tannins, and flavonoids, all of which are responsible for these effects. In addition to its potential as a natural alternative or complementary agent in the control of diabetes, the safety profile and therapeutic uses of Euphorbia hirta are also discussed. To ensure that Euphorbia hirta is as useful as possible in antidiabetic treatment, this review will go over the current evidence, any gaps in the literature, and where researchers should go from here.

Downloads

Published

2026-05-10

How to Cite

Review on Antidiabetic Effects of Euphorbia hirta L. via Digestive Enzyme Inhibition. (2026). International Journal of Pharmaceutical and Healthcare Innovation, 3(2), 1076-1086. https://doi.org/10.62752/ijphi.v3i2.257

Similar Articles

31-39 of 39

You may also start an advanced similarity search for this article.